Abeona Therapeutics Q3 EPS $(0.10) Beats $(0.29) Estimate

Abeona Therapeutics (NASDAQ: ABEO) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.29) by 65.52 percent. This is a 84.13 percent increase over losses of $(0.63) per share from the same period last year.